Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1360 Views
-
Last post by frodo
-
- 0 Replies
- 998 Views
-
Last post by frodo
-
- 0 Replies
- 2311 Views
-
Last post by NHE
-
- 0 Replies
- 1288 Views
-
Last post by frodo
-
- 0 Replies
- 1261 Views
-
Last post by frodo
-
- 0 Replies
- 1241 Views
-
Last post by frodo
-
- 0 Replies
- 1521 Views
-
Last post by NHE
-
- 0 Replies
- 477 Views
-
Last post by NHE
-
- 1 Replies
- 2944 Views
-
Last post by Tif